Association between M1 macrophage polarization and nonalcoholic fatty liver disease induced by high-fat diet

Liu Hua, Meng Qi, Hao Yangmin, Du Guoli

PDF(2330 KB)
PDF(2330 KB)
Journal of Chongqing Medical University ›› 2025, Vol. 50 ›› Issue (05) : 595-601. DOI: 10.13406/j.cnki.cyxb.003743
Basic research

Association between M1 macrophage polarization and nonalcoholic fatty liver disease induced by high-fat diet

Author information +
History +

Abstract

Objective To investigate the flow cytometry cell sorting regimen for M1 macrophages and the association between M1 macrophage polarization and nonalcoholic fatty liver disease(NAFLD). Methods High-fat diet(HFD) was used to establish a mouse model of NAFLD. Twelve C57BL/6 mice were randomly divided into control group(normal diet) and HFD group using a random number table and were fed for 24 weeks. Metabolic markers including blood glucose and blood lipids were measured;quantitative real-time PCR was used to measure the factors associated with M1 macrophages in mice;HE staining was used to observe liver pathology. The Percoll gradient centrifugation method was used to collect liver Kupffer cells,and flow cytometry was used to measure M1 macrophages in mouse liver(sorting regimen:FSC-A/SSC-A for grouping and removing red blood cells and impurities in the liver;FITC CD45(+)/PE-cy7 CD11clow for grouping leukocytes;APC CD115(+)/Percp cy5.5 CD11bhigh for the screening of monocytes;Apc-cy7 F4/80low/PE Ly-6Chigh for separating M1 macrophages). Results Compared with the control group at week 24,the HFD group had significant increases in the indicators of body weight [(28.35±1.71) g vs. (38.43±4.41) g,P<0.001),liver weight [(1.03±0.18) g vs. (1.85±0.41) g,P=0.003),fasting blood glucose [(10.23±1.58) mmol/L vs. (7.07±0.58) mmol/L,P˂0.001)],insulin [(18.62±3.84) pg/mL vs. (28.84±8.3) pg/mL,P˂0.001)],triglyceride [(2.97±0.67) mmol/L vs. (4.05±0.99) mmol/L,P=0.01)],cholesterol[(0.23±0.06) mmol/L vs. (0.55±0.17) mmol/L,P<0.001)],alanine aminotransferase [5.67(3.16,9.23) U/L vs. 35.86(19.68,58.33) U/L,P=0.003],and aspartate aminotransferase [53.14(38.18,64.40) U/L vs. 155.10 (113.60,192.20) U/L,P<0.001],and there was a significant increase in M1 macrophage polarization in NAFLD mice [42.00%(26.50,45.50) vs. 9.95%(3.1,12),P=0.003]. There were significant increases in the mRNA levels of IL-β,IL-6,F4/80,and TNF-α in the liver of mice induced by HFD. Conclusion The flow cytometry sorting regimen can be used to measure M1 macrophages in the liver. Significant aggravation of inflammatory response is observed in NAFLD,and M1 macrophage polarization is positively correlated with the onset of NAFLD.

Key words

nonalcoholic fatty liver disease / flow cytometry / M1 macrophages

Cite this article

Download Citations
Liu Hua , Meng Qi , Hao Yangmin , et al. Association between M1 macrophage polarization and nonalcoholic fatty liver disease induced by high-fat diet. Journal of Chongqing Medical University. 2025, 50(05): 595-601 https://doi.org/10.13406/j.cnki.cyxb.003743

References

1
Han SK Baik SK Kim MY. Non-alcoholic fatty liver disease:definition and subtypes[J]. Clin Mol Hepatol202329(Suppl):S5-S16.
2
Zhou JH Zhou F Wang WX,et al. Epidemiological features of NAFLD from 1999 to 2018 in China[J]. Hepatology202071(5):1851-1864.
3
Estes C Anstee QM Arias-Loste MT,et al. Modeling NAFLD disease burden in China,France,Germany,Italy,Japan,Spain,United Kingdom,and United States for the period 2016-2030[J]. J Hepatol201869(4):896-904.
4
Pouwels S Sakran N Graham Y,et al. Non-alcoholic fatty liver disease(NAFLD):a review of pathophysiology,clinical management and effects of weight loss[J]. BMC Endocr Disord202222(1):63.
5
Friedman SL Neuschwander-Tetri BA Rinella M,et al. Mechanisms of NAFLD development and therapeutic strategies[J]. Nat Med201824(7):908-922.
6
Tan Z Sun HB Xue TX,et al. Liver fibrosis:therapeutic targets and advances in drug therapy[J]. Front Cell Dev Biol20219:730176.
7
Musrati MA De Baetselier P Movahedi K,et al. Ontogeny,functions and reprogramming of Kupffer cells upon infectious disease[J]. Front Immunol202314:1238452.
8
Nguyen-Lefebvre AT Horuzsko A. Kupffer cell metabolism and function[J]. J Enzymol Metab20151(1):101.
9
Xu GX Wei S Yu C,et al. Activation of Kupffer cells in NAFLD and NASH:mechanisms and therapeutic interventions[J]. Front Cell Dev Biol202311:1199519.
10
Nakashima H Kearney BM Kato A,et al. Novel phenotypical and functional sub-classification of liver macrophages highlights changes in population dynamics in experimental mouse models[J]. Cytometry A2023103(11):902-914.
11
Zou YY Kamada N Seong SY,et al. CD115-monocytic myeloid-derived suppressor cells are precursors of OLFM4high polymorphonuclear myeloid-derived suppressor cells[J]. Commun Biol20236:272.
12
Jeannin P Paolini L Adam C,et al. The roles of CSFs on the functional polarization of tumor-associated macrophages[J]. FEBS J2018285(4):680-699.
13
Kaufmann B Reca A Wang BC,et al. Mechanisms of nonalcoholic fatty liver disease and implications for surgery[J]. Langenbeck’s Arch Surg2021406(1):1-17.
14
Younossi Z Anstee QM Marietti M,et al. Global burden of NAFLD and NASH:trends,predictions,risk factors and prevention[J]. Nat Rev Gastroenterol Hepatol201815(1):11-20.
15
Safari Z Gérard P. The links between the gut microbiome and non-alcoholic fatty liver disease(NAFLD)[J]. Cell Mol Life Sci201976(8):1541-1558.
16
Younossi ZM Golabi P de Avila L,et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes:a systematic review and meta-analysis[J]. J Hepatol201971(4):793-801.
17
Palma R Pronio A Romeo M,et al. The role of insulin resistance in fueling NAFLD pathogenesis:from molecular mechanisms to clinical implications[J]. J Clin Med202211(13):3649.
18
Parlar YE Ayar SN Cagdas D,et al. Liver immunity,autoimmunity,and inborn errors of immunity[J]. World J Hepatol202315(1):52-67.
19
Gong J Tu W Liu JM,et al. Hepatocytes:a key role in liver inflammation[J]. Front Immunol202313:1083780.
20
Kumar S Duan QH Wu RX,et al. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis[J]. Adv Drug Deliv Rev2021176:113869.
21
Li L Zeng ZT. Live imaging of innate and adaptive immune responses in the liver[J]. Front Immunol202011:564768.
22
Zhao J Bian DD Liao H,et al. Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients[J]. Front Cell Infect Microbiol202313:1083912.
23
Li HG Zheng J Xu Q,et al. Hepatocyte adenosine kinase promotes excessive fat deposition and liver inflammation[J]. Gastroenterology2023164(1):134-146.
24
Brenner C Galluzzi L Kepp O,et al. Decoding cell death signals in liver inflammation[J]. J Hepatol201359(3):583-594.
25
Getachew Y Cusimano FA James LP,et al. The role of intrahepatic CD3+/CD4-/CD8- double negative T(DN T) cells in enhanced acetaminophen toxicity[J]. Toxicol Appl Pharmacol2014280(2):264-271.
26
Lee YA Friedman SL. Inflammatory and fibrotic mechanisms in NAFLD-Implications for new treatment strategies[J]. J Intern Med2022291(1):11-31.
27
Vonderlin J Chavakis T Sieweke M,et al. The multifaceted roles of macrophages in NAFLD pathogenesis[J]. Cell Mol Gastroenterol Hepatol202315(6):1311-1324.
28
Hoogerland JA Staels B Dombrowicz D. Immune-metabolic interactions in homeostasis and the progression to NASH[J]. Trends Endocrinol Metab202233(10):690-709.
29
Gadd VL Skoien R Powell EE,et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease[J]. Hepatology201459(4):1393-1405.
30
Zhou JW Tang ZW Gao SY,et al. Tumor-associated macrophages:recent insights and therapies[J]. Front Oncol202010:188.
31
Fleetwood AJ Lawrence T Hamilton JA,et al. Granulocyte-macrophage colony-stimulating factor(CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities:implications for CSF blockade in inflammation[J]. J Immunol2007178(8):5245-5252.
32
Kadomoto S Izumi K Mizokami A. Macrophage polarity and disease control[J]. Int J Mol Sci202123(1):144.
33
Jenkins SJ Ruckerl D Thomas GD,et al. IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1[J]. J Exp Med2013210(11):2477-2491.
34
Chen YN Hu MR Wang L,et al. Macrophage M1/M2 polarization[J]. Eur J Pharmacol2020877:173090.
35
Luo WJ Xu QY Wang Q,et al. Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease[J]. Sci Rep20177:44612.
36
Sun C Luo QB Lu XX,et al. Isolation and purification of primary Kupffer cells from mouse liver[J]. BMJ201632(8):1021-1025.
37
Aktories P Petry P Glatz P,et al. An improved organotypic cell culture system to study tissue-resident macrophages ex vivo [J]. Cell Rep Methods20222(8):100260.
38
Dong ZJ Wei HM Sun R,et al. Isolation of murine hepatic lymphocytes using mechanical dissection for phenotypic and functional analysis of NK1.1 cells[J]. World J Gastroenterol200410(13):1928-1933.
39
Zhang C Lu Y Zhou H,et al. Acquiring Kupffer cells in mice using a MACS-based method[J]. Transplant Proc201547(2):553-557.
40
Waddell LA Lefevre L Bush SJ,et al. ADGRE1(EMR1,F4/80) is a rapidly-evolving gene expressed in mammalian monocyte-macrophages[J]. Front Immunol20189:2246.
41
Liyanage SE Gardner PJ Ribeiro J,et al. Flow cytometric analysis of inflammatory and resident myeloid populations in mouse ocular inflammatory models[J]. Exp Eye Res2016151:160-170.
42
Blom KG Qazi MR Noronha Matos JB,et al. Isolation of murine intrahepatic immune cells employing a modified procedure for mechanical disruption and functional characterization of the B,T and natural killer T cells obtained[J]. Clin Exp Immunol2009155(2):320-329.
43
Pertoft H. Fractionation of cells and subcellular particles with Percoll[J]. J Biochem Biophys Methods200044(1/2):1-30.

Comments

PDF(2330 KB)

Accesses

Citation

Detail

Sections
Recommended

/